- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about alcohol use disorder
Recent news which mentions alcohol use disorder
Can CBD Help With Alcohol Use Disorder? New Scientific Review Finds There's Something To It
March 22, 2024
Tickers
NEWS
From Benzinga
Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors
March 12, 2024
From Benzinga
Awakn Life Sciences Submits CTA For Phase III Alcohol Use Disorder Clinical Trial
September 06, 2023
Tickers
AWKNF
From Benzinga
Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials
August 23, 2023
Tickers
FLHLF
From Benzinga
Awakn Life Sciences Sells London Clinics Business, Hopes To Divest Norwegian Unit Next
July 05, 2023
Tickers
AWKNF
From Benzinga
From Benzinga
FSD Pharma Announces Agreement To Grant Exclusive Rights To Recreational Alcohol Misuse Technology
June 20, 2023
From Benzinga
Awakn To Focus On R&D Of Addiction Therapies, Moves Away From Ketamine Treatment For Alcoholism
June 12, 2023
Tickers
AWKNF
From Benzinga
From Benzinga
EXCLUSIVE: Clearmind Medicine Secures Approval To Launch Clinical Trial For Alcohol Addiction Treatment
May 12, 2023
Tickers
CMND
From Benzinga
Awakn's Q4 2023 And Annual Financials, +500% YoY Revenue Increase Following Network Expansion
April 28, 2023
Tickers
AWKNF
From Benzinga
UK-Based Approach To Alcohol Addiction: 5-MeO-DMT Candidate Moves To Phase 2 Clinical Stage
April 05, 2023
From Benzinga
Shark Tank's Kevin Harrington Will Provide Strategic Guidance To Major Psychedelics Company
February 28, 2023
Tickers
HUGE
From Benzinga
Awakn's First Licensing Partnership Deal In Europe Involves Chain Of Portuguese Clinics
February 22, 2023
Tickers
AWKNF
From Benzinga
Psychedelics For Alcohol Use Disorder: Awakn Opens European Clinic, FSD Launches R&D Program
February 14, 2023
From Benzinga
Clinical Site In Alberta Begins Study Of Psychedelic-Assisted Treatment For Alcohol Use Disorder
February 07, 2023
From Benzinga
Awakn's Ketamine Treatment For Alcohol Use Disorder Awarded UK's Fast-Track Status
February 07, 2023
Tickers
AWKNF
From Benzinga
Recreational Cannabis Legalization Correlated With Decrease In Alcohol Use Disorder, New Study Finds
January 30, 2023
From Benzinga
EXCLUSIVE: Next-Generation Psychedelics, MEAI - What And When
January 24, 2023
Tickers
CMND
From Benzinga
Psychiatry And Business Collaborate: European Psychedelics Trial Tackles Alcohol Addiction
January 20, 2023
Tickers
FLHLF
From Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
January 03, 2023
From Benzinga
47% of Adults With Alcohol Use Disorder Sought Help Because of Family Encouragement
December 08, 2022
Tickers
ALKS
Europe To Have Expanded Access To Psychedelic-Assisted Therapy With New Norway Clinic
December 03, 2022
Tickers
AWKNF
From Benzinga
A Leading Ketamine Treatment Clinic For Alcoholism Is Expanding: Here's The Latest
November 23, 2022
Tickers
AWKNF
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.